ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 400,500 shares, a growth of 16.5% from the February 13th total of 343,900 shares. Based on an average daily trading volume, of 126,700 shares, the days-to-cover ratio is presently 3.2 days. Approximately 1.5% of the shares of the stock are sold short.
ZimVie Price Performance
NASDAQ:ZIMV traded up $0.06 during trading hours on Friday, reaching $11.66. 318,522 shares of the company were exchanged, compared to its average volume of 233,145. The company has a market capitalization of $322.71 million, a P/E ratio of -0.89 and a beta of 2.10. ZimVie has a 1-year low of $11.35 and a 1-year high of $22.40. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The business has a 50 day moving average of $13.31 and a 200 day moving average of $14.24.
ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Research analysts forecast that ZimVie will post 0.6 EPS for the current year.
Analyst Upgrades and Downgrades
Separately, Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research report on Thursday, March 13th.
View Our Latest Analysis on ZimVie
Institutional Investors Weigh In On ZimVie
A number of large investors have recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of ZimVie by 5.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company's stock valued at $211,000 after purchasing an additional 836 shares in the last quarter. J. Goldman & Co LP boosted its holdings in shares of ZimVie by 167.5% in the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company's stock valued at $19,890,000 after purchasing an additional 892,785 shares in the last quarter. Forest Hill Capital LLC boosted its holdings in shares of ZimVie by 25.9% in the 4th quarter. Forest Hill Capital LLC now owns 172,809 shares of the company's stock valued at $2,411,000 after purchasing an additional 35,500 shares in the last quarter. Deutsche Bank AG boosted its holdings in shares of ZimVie by 61.7% in the 4th quarter. Deutsche Bank AG now owns 23,796 shares of the company's stock valued at $332,000 after purchasing an additional 9,084 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. boosted its holdings in shares of ZimVie by 12.1% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 301,316 shares of the company's stock valued at $4,203,000 after purchasing an additional 32,551 shares in the last quarter. Institutional investors and hedge funds own 95.63% of the company's stock.
ZimVie Company Profile
(
Get Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
See Also
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.